Literature DB >> 26846533

ACR CT Accreditation Program and the Lung Cancer Screening Program Designation.

Ella A Kazerooni1, Mark R Armstrong2, Judith K Amorosa3, Dina Hernandez4, Lawrence A Liebscher5, Hrudaya Nath6, Michael F McNitt-Gray7, Eric J Stern8, Pamela A Wilcox9.   

Abstract

The ACR recognizes that low-dose CT for lung cancer screening has the potential to significantly reduce mortality from lung cancer in the appropriate high-risk population. The ACR supports the recommendations of the US Preventive Services Task Force and the National Comprehensive Cancer Network for screening patients. To be effective, lung cancer screening should be performed at sites providing high-quality low-dose CT examinations overseen and interpreted by qualified physicians using a structured reporting and management system. The ACR has developed a set of tools necessary for radiologists to take the lead on the front lines of lung cancer screening. The ACR Lung Cancer Screening Center designation is built upon the ACR CT accreditation program and requires use of Lung-RADS or a similar structured reporting and management system. This designation provides patients and referring providers with the assurance that they will receive high-quality screening with appropriate follow-up care.
Copyright © 2015 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2016        PMID: 26846533     DOI: 10.1016/j.jacr.2015.12.010

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  10 in total

1.  The need for standardization of nuclear cardiology reporting and data system (NCAD-RADS): Learning from coronary artery disease (CAD), breast imaging (BI), liver imaging (LI), and prostate imaging (PI) RADS.

Authors:  Majid Assadi; Erik Velez; Mohammad Hosein Najafi; Ali Gholamrezanezhad
Journal:  J Nucl Cardiol       Date:  2018-10-29       Impact factor: 5.952

Review 2.  Screening for early stage lung cancer and its correlation with lung nodule detection.

Authors:  Fangfei Qian; Wenjia Yang; Qunhui Chen; Xueyan Zhang; Baohui Han
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Estimating lung, breast, and effective dose from low-dose lung cancer screening CT exams with tube current modulation across a range of patient sizes.

Authors:  Anthony J Hardy; Maryam Bostani; Kyle McMillan; Maria Zankl; Cynthia McCollough; Chris Cagnon; Michael McNitt-Gray
Journal:  Med Phys       Date:  2018-09-24       Impact factor: 4.071

Review 4.  Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.

Authors:  Asha Bonney; Reem Malouf; Corynne Marchal; David Manners; Kwun M Fong; Henry M Marshall; Louis B Irving; Renée Manser
Journal:  Cochrane Database Syst Rev       Date:  2022-08-03

Review 5.  Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Douglas E Wood; Ella A Kazerooni; Scott L Baum; George A Eapen; David S Ettinger; Lifang Hou; David M Jackman; Donald Klippenstein; Rohit Kumar; Rudy P Lackner; Lorriana E Leard; Inga T Lennes; Ann N C Leung; Samir S Makani; Pierre P Massion; Peter Mazzone; Robert E Merritt; Bryan F Meyers; David E Midthun; Sudhakar Pipavath; Christie Pratt; Chakravarthy Reddy; Mary E Reid; Arnold J Rotter; Peter B Sachs; Matthew B Schabath; Mark L Schiebler; Betty C Tong; William D Travis; Benjamin Wei; Stephen C Yang; Kristina M Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2018-04       Impact factor: 11.908

6.  Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.

Authors:  Rafael Meza; Jihyoun Jeon; Iakovos Toumazis; Kevin Ten Haaf; Pianpian Cao; Mehrad Bastani; Summer S Han; Erik F Blom; Daniel E Jonas; Eric J Feuer; Sylvia K Plevritis; Harry J de Koning; Chung Yin Kong
Journal:  JAMA       Date:  2021-03-09       Impact factor: 157.335

7.  Observer variability for Lung-RADS categorisation of lung cancer screening CTs: impact on patient management.

Authors:  Sarah J van Riel; Colin Jacobs; Ernst Th Scholten; Rianne Wittenberg; Mathilde M Winkler Wille; Bartjan de Hoop; Ralf Sprengers; Onno M Mets; Bram Geurts; Mathias Prokop; Cornelia Schaefer-Prokop; Bram van Ginneken
Journal:  Eur Radiol       Date:  2018-07-31       Impact factor: 5.315

8.  Patient size matters: Effect of tube current modulation on size-specific dose estimates (SSDE) and image quality in low-dose lung cancer screening CT.

Authors:  Izabella Barreto; Nupur Verma; Nathan Quails; Catherine Olguin; Nathalie Correa; Tan-Lucien Mohammed
Journal:  J Appl Clin Med Phys       Date:  2020-04-06       Impact factor: 2.102

9.  Evaluation of ultralow-dose computed tomography on detection of pulmonary nodules in overweight or obese adult patients.

Authors:  Xiaowan Guo; Dezhao Jia; Lei He; Xudong Jia; Danqing Zhang; Yana Dou; Shanshan Shen; Hong Ji; Shuqian Zhang; Yingmin Chen
Journal:  J Appl Clin Med Phys       Date:  2022-03-16       Impact factor: 2.102

10.  A radiomics model can distinguish solitary pulmonary capillary haemangioma from lung adenocarcinoma.

Authors:  Hao-Jen Wang; Mong-Wei Lin; Yi-Chang Chen; Li-Wei Chen; Min-Shu Hsieh; Shun-Mao Yang; Ho-Feng Chen; Chuan-Wei Wang; Jin-Shing Chen; Yeun-Chung Chang; Chung-Ming Chen
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.